NTRA and ALLO Related Headlines

Go Back

Apr 13, 2026 08:00AM Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma

NTRA and ALLO Related Press Releases

Go Back

Apr 13, 2026 08:00AM Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma

NTRA and ALLO Related SEC Filings

Go Back